Bausch + Lomb Corp. announced an amendment to the employment agreement with its CEO, Brenton L. Saunders, on July 21, 2025. The amendment modifies Mr. Saunders' "good reason" severance rights related to the company's spin-off from Bausch Health Companies Inc. Additionally, the terms of Saunders' performance stock units have been revised. These units will now vest and payout between 120% and 330% of the target by February 23, 2029, based on achieving specific share-price hurdles and a new cumulative Adjusted EBITDA performance goal for the fiscal years 2025-2028. The full text of these amendments will be available in the company's upcoming Quarterly Report on Form 10-Q.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。